NuVasive Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
NuVasive (NUVA) PT Raised to $65 at Leerink Partners Amid Solid Q2
July 29, 2015 7:59 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $57.00) following solid Q2 results.
Newitter commented, "NUVA's 2Q was solid with 8.5% cc rev growth & margin/EPS upside. 2015 guidance (rev unchgd; mgn/EPS... More
Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat
July 29, 2015 7:35 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $56.00 (from $55.00), following a 2Q15 EPS beat. NUVA reported non-GAAP EPS of $0.31, $0.06 above consensus estimates of $0.25. Revenues for the quarter came in at $202.9M, versus consensus of $200.7M. NUVA... More
Northland Capital Markets Upgrades NuVasive (NUVA) to Outperform
July 29, 2015 7:06 AM EDTNorthland Capital Markets upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform with a price target of $68.00.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $50.47 yesterday.
... MoreNuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJ
July 28, 2015 4:39 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $202.9 million versus the consensus estimate of $200.71 million.
NuVasive sees FY2015 EPS of $1.17, versus the consensus of $1.12. NuVasive sees FY2015 revenue of $810.0 million, versus the consensus of $812.2 million.
The company also has reached a definitive settlement with the U.S. Department... More
